Rare diseases
Investigational molecules
Locations
353 conditions with trials, the busiest first
844 trials across Europe, recruiting first
Study on Itacitinib for Adults with Diffuse Systemic Sclerosis
FranceStudy on L19IL2 and L19TNF Treatment Before Surgery for Patients with Advanced Melanoma
FranceStudy of dupilumab effectiveness compared to placebo in adults with bullous pemphigoid
FranceStudy on Ceralasertib and Durvalumab for Patients with Advanced Melanoma Resistant to PD-(L)1 Therapy
BelgiumStudy on Sirolimus for Adults with Facial Skin Sarcoidosis: Evaluating Treatment for Moderate to Severe Cases
FranceStudy on Long-Term Safety and Effectiveness of Bimekizumab for Adults with Moderate to Severe Hidradenitis Suppurativa
BulgariaStudy of Hydroxychloroquine Safety and Effectiveness in Patients with Early Systemic Sclerosis
ItalyStudy on the Effectiveness and Safety of 0.1% Mometasone Furoate Emulsion and Ecural Cream for Adults with Plaque Psoriasis
PolandStudy of Nivolumab for Patients with High-Risk Stage II Melanoma After Surgery
GermanyStudy on Prednisone and Antihistamine for Treating Acute Urticaria in Adults at the Emergency Department
FranceStudy Comparing Methylprednisolone Aceponate Ointment and a Drug Combination for Patients with Mild to Moderate Atopic Dermatitis
GermanyStudy of remibrutinib for long-term treatment of adult patients with chronic spontaneous urticaria who completed previous remibrutinib studies
BulgariaThe therapies tested most often in Skin and subcutaneous tissue disorders trials.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
